This is a non-core endpoint: only basic statistics are computed.
Other and unspecified vaccines and biological substances
VWXY20_OTHER_UNSPE_VACCINES_BIOLO_SUBST
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
192
Check minimum number of events None
192
Include endpoints None
192
Remove individuals based on genotype QC
175
VWXY20_OTHER_UNSPE_VACCINES_BIOLO_SUBST
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Y[4-5]
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Other and unspecified vaccines and biological substances
based on the number of shared cases.
Broader endpoints:
- Drugs, medicaments and biological substances causing adverse effects in therapeutic use
- Complications of medical and surgical care
- External causes of morbidity and mortality
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 175 | 131 | 44 |
| Unadjusted prevalence (%) | 0.04 | 0.06 | 0.02 |
| Mean age at first event (years) | 47.19 | 46.55 | 49.07 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: VWXY20_OTHER_UNSPE_VACCINES_BIOLO_SUBST – Other and unspecified vaccines and biological substances
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Other and unspecified vaccines and biological substances
↥Endpoint not on priority list, no data to show.